PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • The claims in these various patents and patent applications are directed to additional compositions of matter of oritavancin, including claims covering product candidates, lead compounds and key intermediates, pharmaceutical compositions,
http://www.w3.org/ns/prov#wasQuotedFrom
  • sec.gov